Cocrystal Pharma Inc.
COCP | NASDAQ
$1.22
+$0.01 (+0.83%)
At close: Sep 21, 2026, 3:59 PM ET
$1.19
-$0.03 (-2.46%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 2.01M |
Cost of Revenue | 5.06M | 12.54M | 15.17M | 12.39M | 8.79M | 6.03M |
Gross Profit | -5.06M | -12.54M | -15.17M | -12.39M | -8.79M | -4.02M |
Operating Income | -9.02M | -17.88M | -18.56M | -38.83M | -14.22M | -9.59M |
Interest Income | 134K | 537K | 640K | 2 | 4 | n/a |
Pretax Income | -8.83M | -17.5M | -17.98M | -38.84M | -14.19M | -9.65M |
Net Income | -8.83M | -17.5M | -17.98M | -38.84M | -14.19M | -9.65M |
Selling & General & Admin | 3.96M | 5.34M | 5.99M | 5.75M | 5.43M | 5.57M |
Research & Development | 5.06M | 12.54M | 15.17M | 12.39M | 8.79M | 6.03M |
Other Expenses | -5.06M | -12.54M | -17.77M | 8.3M | -8.79M | -6.03M |
Operating Expenses | 3.96M | 5.34M | 3.39M | 26.44M | 5.43M | 5.57M |
Interest Expense | n/a | n/a | n/a | 2K | 4K | 8K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.02M | 17.88M | 18.56M | 38.83M | 14.22M | 11.6M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.29M | 10.17M | 9.65M | 8.14M | 7.69M | 4.8M |
Shares Outstanding (Diluted) | 11.29M | 10.17M | 9.65M | 8.14M | 7.69M | 4.8M |
EPS (Basic) | -0.78 | -1.72 | 0 | -4.77 | -1.85 | -2.01 |
EPS (Diluted) | -0.78 | -1.72 | 0 | -4.77 | -1.85 | -2.01 |
EBITDA | -8.46M | -17.38M | -20.97M | -17.95M | -13.99M | -9.43M |
EBIT | -8.83M | -17.5M | -21.16M | -18.14M | -14.18M | -9.59M |
Depreciation & Amortization | 376K | 126K | 189K | 185K | 190K | 157K |
Add to Watchlist
Select watchlists to add or remove COCP